Oral lasofoxifene&#39;s effects on moderate to severe vaginal atrophy in postmenopausal women: two phase 3, randomized, controlled trials.

lasofoxifene topical - Azure Biotech

Fablyn (lasofoxifene) - Sermonix

http://www.ncbi.nlm.nih.gov/pubmed/38652875

Barry S Komm; David J Portman; James A Simon; Risa Kagan; Simon N Jenkins; Steven R Goldstein

Apr 24, 2024